Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros












Base de dados
Intervalo de ano de publicação
2.
Rev Epidemiol Sante Publique ; 65(6): 443-452, 2017 Nov.
Artigo em Francês | MEDLINE | ID: mdl-29110959

RESUMO

BACKGROUND: France has a complex system for the taxation of alcoholic beverages. In the French overseas territories (FOT), the system includes little-known specificities whose purpose is to preserve the sugar-cane-rum sector, a pillar for the weak economies in these territories. Taxes are reduced for traditional rums produced and sold locally. This favors the marketing of alcoholic spirits at low prices. In metropolitan France, on the contrary, spirits are heavily taxed drinks and their share in consumption is minor. Reunion Island (RI) is a FOT confronted with significant socioeconomic precariousness and with one of the highest national morbidity and mortality rates associated with alcohol abuse. Spirits account for half of the total consumption of pure alcohol, with a strong predominance for local traditional rums. These products are preferentially consumed by vulnerable subjects, often affected by an alcohol-use disorder. METHODS: This study consists of three parts. First, a comparative analysis of alcoholic beverage prices between RI and mainland France. Second, an analysis of the bibliography on the consequences of preferential consumption of spirits. Third, a literature review on the impact of taxation on alcohol-related morbidity and mortality. RESULTS: In France, the cheapest gram of pure alcohol is found in the FOT. The preferential consumption of spirits is associated with more frequent and more rapid complications. It is correlated with the level of alcoholic psychoses. Taxation is effective in reducing damage caused by the abuse of alcoholic beverages. The World Health Organization recommends the application of a minimum price for alcohol and tax increases. CONCLUSION: The reduced taxation of the traditional rums of the FOT does not take into account public health data. Its purpose is economic. In RI, it contributes to a high level of consumption of spirits and encourages excess mortality through alcohol abuse. It constitutes an inequality of health for these populations. Changes in this tax system is desirable in order to reduce the harm caused by alcohol. It should be closer to the tax system in force in metropolitan France. Alcohol lobbies and lack of political courage have so far inhibited this change to the detriment of the health of the populations.


Assuntos
Bebidas Alcoólicas , Comércio , Cultura , Saúde Pública , Impostos , Consumo de Bebidas Alcoólicas/economia , Consumo de Bebidas Alcoólicas/epidemiologia , Transtornos do Sistema Nervoso Induzidos por Álcool/epidemiologia , Bebidas Alcoólicas/efeitos adversos , Bebidas Alcoólicas/economia , Bebidas Alcoólicas/estatística & dados numéricos , Comércio/estatística & dados numéricos , França/epidemiologia , Humanos , Morbidade , Mortalidade , Psicoses Induzidas por Substâncias/economia , Psicoses Induzidas por Substâncias/epidemiologia , Saúde Pública/economia , Saúde Pública/normas , Saúde Pública/estatística & dados numéricos , Reunião/epidemiologia , Impostos/estatística & dados numéricos
4.
Ann Pharmacother ; 32(9): 906-14, 1998 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-9762379

RESUMO

OBJECTIVE: To review and highlight the opportunities and challenges of pharmacologic advances in the use of antipsychotics for the state hospital system. METHODS: A critical review was performed of studies published either as articles or abstracts, on the use of novel antipsychotics, particularly as they relate to the patient population within the state mental hospital system. FINDINGS: The recent availability of new antipsychotic medications within state facilities has resulted in more progressive treatment, reduced recidivism (and consequently cost savings), and preliminary evidence of preferential and superior treatment response in specific patient subgroups (e.g., those with aggression). At the same time, inpatient pharmacy budget increases and uncertainty in guiding the use of novel antipsychotics have influenced the availability of these agents in state hospitals. CONCLUSIONS: State hospital services have, by and large, embraced the developments in pharmacotherapy of schizophrenia. Optimal use of these new agents in this population requires additional information on their relative efficacy in specific patient subgroups.


Assuntos
Antipsicóticos/uso terapêutico , Hospitais Psiquiátricos/normas , Hospitais Estaduais/normas , Transtornos Psicóticos/tratamento farmacológico , Esquizofrenia/tratamento farmacológico , Agressão/efeitos dos fármacos , Antipsicóticos/economia , Hospitais Psiquiátricos/economia , Hospitais Estaduais/economia , Humanos , Psicoses Induzidas por Substâncias/tratamento farmacológico , Psicoses Induzidas por Substâncias/economia , Psicoses Induzidas por Substâncias/psicologia , Transtornos Psicóticos/complicações , Transtornos Psicóticos/economia , Transtornos Psicóticos/psicologia , Esquizofrenia/economia , Transtornos Relacionados ao Uso de Substâncias/complicações , Transtornos Relacionados ao Uso de Substâncias/tratamento farmacológico , Transtornos Relacionados ao Uso de Substâncias/economia , Transtornos Relacionados ao Uso de Substâncias/psicologia , Estados Unidos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...